Medical progress: Infection in solid-organ transplant recipients

[1] Heterologous immunity provides a potent barrier to transplantation tolerance [J]. JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (12) : 1887 - 1895

[2] Impact of donor infections on outcome of orthotopic liver transplantation [J]. LIVER TRANSPLANTATION, 2003, 9 (05) : 451 - 462

[3] Prophylactic strategies before solid-organ transplantation [J]. CURRENT OPINION IN INFECTIOUS DISEASES, 2004, 17 (04) : 353 - 356

[4] Visceral leishmaniasis in organ transplant recipients: 11 new cases and a review of the literature [J]. MICROBES AND INFECTION, 2005, 7 (13) : 1370 - 1375

[5] Risk factors for Staphylococcus aureus infection in liver transplant recipients [J]. LIVER TRANSPLANTATION, 2005, 11 (09) : 1093 - 1099

[6] Boivin G, 2006, TRANSPL INFECT DIS, V8, P58

[7] Clinical impact of ganciclovir-resistant cytomegalovirus infections in solid organ transplant patients [J]. TRANSPLANT INFECTIOUS DISEASE, 2005, 7 (3-4) : 166 - 170

[8] Visceral leishmaniasis in renal transplant recipients: Successful treatment with liposomal amphotericin B (AmBisome) [J]. CLINICAL INFECTIOUS DISEASES, 1999, 28 (06) : 1308 - 1309

[9] Visceral leishmaniasis in a renal transplant recipient -: Short review and therapy alternative [J]. AMERICAN JOURNAL OF NEPHROLOGY, 1998, 18 (02) : 171 - 171

[10] Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P210

[1] Heterologous immunity provides a potent barrier to transplantation tolerance [J]. JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (12) : 1887 - 1895

[2] Impact of donor infections on outcome of orthotopic liver transplantation [J]. LIVER TRANSPLANTATION, 2003, 9 (05) : 451 - 462

[3] Prophylactic strategies before solid-organ transplantation [J]. CURRENT OPINION IN INFECTIOUS DISEASES, 2004, 17 (04) : 353 - 356

[4] Visceral leishmaniasis in organ transplant recipients: 11 new cases and a review of the literature [J]. MICROBES AND INFECTION, 2005, 7 (13) : 1370 - 1375

[5] Risk factors for Staphylococcus aureus infection in liver transplant recipients [J]. LIVER TRANSPLANTATION, 2005, 11 (09) : 1093 - 1099

[6] Boivin G, 2006, TRANSPL INFECT DIS, V8, P58

[7] Clinical impact of ganciclovir-resistant cytomegalovirus infections in solid organ transplant patients [J]. TRANSPLANT INFECTIOUS DISEASE, 2005, 7 (3-4) : 166 - 170

[8] Visceral leishmaniasis in renal transplant recipients: Successful treatment with liposomal amphotericin B (AmBisome) [J]. CLINICAL INFECTIOUS DISEASES, 1999, 28 (06) : 1308 - 1309

[9] Visceral leishmaniasis in a renal transplant recipient -: Short review and therapy alternative [J]. AMERICAN JOURNAL OF NEPHROLOGY, 1998, 18 (02) : 171 - 171

[10] Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P210